Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2022Biomedicine & PharmacotherapyOpen Access

Recent advances in ginsenosides against respiratory diseases: Therapeutic targets and potential mechanisms

View Full Paper
Ask AI
Bookmark
Share

Authors

LDLu DingJilin UniversityHQHongyu QiChangchun University of Chinese MedicineYWYisa WangChangchun University of Chinese Medicine

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ding et al. (2022) studied this question.

synapsesocial.com/papers/6a18b32a84137bd80e91a644https://doi.org/10.1016/j.biopha.2022.114096
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Effectiveness of honey for symptomatic relief in upper respiratory tract infections: a systematic review and meta-analysis2020 · 97 citations
  2. 2Ginseng polysaccharides alter the gut microbiota and kynurenine/tryptophan ratio, potentiating the antitumour effect of antiprogrammed cell death 1/programmed cell death ligand 1 (anti-PD-1/PD-L1) immunotherapy2021 · 542 citations
  3. 3Ginsenosides from Korean Red Ginseng ameliorate lung inflammatory responses: inhibition of the MAPKs/NF-κB/c-Fos pathways2017 · 72 citations
  4. 420(S)-Ginsenoside Rg3 Inhibits Lung Cancer Cell Proliferation by Targeting EGFR-Mediated Ras/Raf/MEK/ERK Pathway2021 · 53 citations